Received 21 April 2008/Returned for modification 1 July 2008/Accepted 20 August 2008
|
|
- Homer Marshall Robinson
- 5 years ago
- Views:
Transcription
1 JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 2008, p Vol. 46, No /08/$ doi: /jcm Copyright 2008, American Society for Microbiology. All Rights Reserved. Detection of Perinatal Cytomegalovirus Infection and Sensorineural Hearing Loss in Belgian Infants by Measurement of Automated Auditory Brainstem Response Jannick Verbeeck, 1 Erwin Van Kerschaver, 2 Elke Wollants, 1 Kurt Beuselinck, 3 Luc Stappaerts, 2 and Marc Van Ranst 1 * Laboratory of Clinical Virology, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium 1 ; Kind & Gezin (K&G), Brussels, Belgium 2 ; and Laboratory of Molecular Diagnostics, University Hospital Gasthuisberg, Leuven, Belgium 3 Received 21 April 2008/Returned for modification 1 July 2008/Accepted 20 August 2008 Since auditory disability causes serious problems in the development of speech and in the total development of a child, it is crucial to diagnose possible hearing impairment as soon as possible after birth. This study evaluates the neonatal hearing screening program in Flanders, Belgium. The auditory ability of 118,438 babies was tested using the automated auditory brainstem response. We selected 194 babies with indicative hearing impairment and 332 matched controls to investigate the association between the presence of human cytomegalovirus (HCMV) in urine samples and sensorineural hearing loss and to analyze the sensibility and specificity of a assay and a quantitative PCR detection method. Our results indicate that significantly more babies with confirmed hearing impairment were HCMV positive after birth. Further, based on the results of our study, babies with HCMV viral loads above 4.5 log copies/ml urine seem to be 1.4 times more likely to have confirmed hearing impairment. Our follow-up study suggests that the hearing impairment of children infected with HCMV after birth is less likely to improve than that of HCMV-negative infants. Our results confirm that the presence of HCMV before or shortly after birth influences the outcome of hearing impairment. Human cytomegalovirus (HCMV) is a species-specific member of the betaherpesvirus family. Although HCMV infection in healthy children and adults usually is asymptomatic, it is the leading cause of nongenetic sensorineural hearing loss (a type of hearing loss that is caused by deficits in the vestibulocochlear nerve, in the inner ear, or in the central processing centers of the brain) in developed countries (21, 23, 27). Approximately 14% of the infections are diagnosed at birth, while the remaining 86% are asymptomatic (22). HCMV causes mild or subclinical diseases in immunocompromised individuals, such as transplant recipients and AIDS patients (16, 25, 33). The seropositivity rate in the adult population is 60 to 100% (1). This high rate possibly is due to the transmission of the virus through close interpersonal contact, breastfeeding, sexual contact, and spread among children. The congenital transmission of HCMV is possible even when maternal immunity is present (19). The incidence of congenitally acquired HCMV in newborns ranges from 0.5 to 2.2% in developed countries (2, 6, 11, 18), but this could be an underestimation, since reliable and national-level estimates are not available (14). Up to 22% of neonates with hearing impairment are infected with HCMV (9). The first report on the association between HCMV infection and hearing impairment dates from 1964 (20). Since then, considerable efforts have been made to clarify the exact mechanism of causing hearing loss, but until now this question has not been resolved. Auditory disability has pernicious effects on the development of speech and on the * Corresponding author. Mailing address: Laboratory of Clinical Virology, Rega Institute for Medical Research, Minderbroedersstraat 10, BE-3000 Leuven, Belgium. Phone: Fax: marc.vanranst@uz.kuleuven.be. Published ahead of print on 3 September total development of the child. The age of onset of a child s hearing impairment and the age at which the hearing impairment is diagnosed are crucial parameters for the further development of the child. Intensive auditive stimulation of the cerebral cortex before the age of 6 months leads to significantly higher language abilities of the disabled children compared to those of children who do not receive a hearing aid until the age of 7 to 18 months (26, 34). For this reason, universal screening for hearing impairment in babies is very important, and this is one of the aims of the Joint Committee on Infant Hearing (JCIH) and the American Academy of Pediatrics. The JCIH guidelines strongly suggest screening before the age of 1 month, with audiological confirmation by 3 months of age in infants who fail the screening test and the initiation of intervention before the age of 6 months (17). The Flanders region in Belgium was the first region in the world to introduce a universal hearing screening program for the whole population (10). Since 1998, more than 90% of the babies born in Flanders have been screened for hearing defects by the district nurses from Child & Family, a Flemish public agency whose purpose is to promote the welfare and health of all children up to the age of 3 years (28, 29). The district nurses of Child & Family have contact with virtually all newborn babies via visits at the maternity ward, house calls, or consultations at the welfare baby clinic (8). During these visits, every new mother is made aware of hearing impairment screening. At the age of about 4 weeks, the hearing test (the automated auditory brainstem response, or AABR) is carried out by the district nurse. If potential hearing impairment is detected at the first test, a second test is performed within 48 h in the presence of a baby clinic medical officer, who examines the ears of the child. If the second test is again positive, the baby is immediately referred 3564
2 VOL. 46, 2008 PERINATAL CMV INFECTION AND HEARING IMPAIRMENT 3565 FIG. 1. Schematic overview of the study population. to a specialized center where the hearing abilities will be further examined. In order to determine the effect of perinatal HCMV infection on hearing impairment, we collected urine samples from newborns with hearing impairment and from healthy controls to examine the presence of HCMV. Children with hearing impairment were enrolled in a follow-up program for at least 2 years in order to assess whether their hearing impairment status changed. MATERIALS AND METHODS Study population. The auditory ability of 118,438 babies, born between April 2002 and April 2004, was tested with the AABR in two phases. Out of the 194 babies with possible hearing impairment, 45 tested positive for the first test and negative for the second test, and 149 tested positive for both tests. Group 1 contains all babies without confirmed hearing impairment that tested positive for the first test and negative for the second test (n 43) and all babies without confirmed hearing impairment that tested positive for both tests (n 15). In total, group 1 contains 58 subjects. Group 2 consists of all babies with confirmed hearing impairment and a positive result on both tests (n 134) and all babies with confirmed hearing impairment who tested positive for the first test and negative for the second test (n 2). Group 2 contains 136 babies in total. For each baby included in this study, the first two babies born in the same region (in a radius of 10 km) and in the same month were matched as controls. Of these, 332 were willing to take part in the study, resulting in a complete data set of 526 babies (Fig. 1). Informed consents were obtained for all children included in this study. Algo hearing screening. To evaluate the hearing system of the infants, the AABR or Algo test (Natus Med. Inc., San Carlos, CA) was carried out 4 to 6 weeks after birth at the infant s home. The automated Algo neonatal hearing screener provides a pass-fail report. The apparatus does not require a special test environment or a person who is audiologically trained to interpret the test result. With this apparatus, both ears are automatically tested, and it corrects for ambient noise and for myogenic interference to ensure that data collections are favorable. All tests were carried out in a two-phase screening; babies who tested positive for the first test were given a second test within 48 h to confirm the result. Normal hearing was defined as thresholds of 35 db at an acoustic frequency spectrum of 700 to 5,000 Hz. Sample collection and isolation of HCMV from urine samples. Urine samples from patients and controls were collected in a time period of 10 to 322 days after birth (average, 49 days). Samples were shipped to the Department of Laboratory Medicine, University Hospital, Leuven, Belgium, where they were immediately stored at 80 C upon arrival. Viral DNA was extracted by using the QIAamp DNA blood mini kit (Qiagen Benelux, Leusden, The Netherlands) according to the manufacturer s instructions. Cell culture assay. Cell culture assays were performed immediately upon the arrival of the samples. Shell vial assays were carried out in embryonic skin muscle cells propagated in 10% minimal essential medium (MEM; Gibco, Life Technologies, Rockville, MD) supplemented with 10% fetal calf serum (FCS; Integro, Zaandam, The Netherlands), mycoplasma removal agent (0.1 ml in 10 ml 10% MEM), and 0.5% sodium bicarbonate (Gibco). The cell suspension was maintained at 37 C in a humidified 5% CO 2 atmosphere. Before inoculation, MEM was removed from the shell vial, and 0.5 ml urine was added directly to the cell monolayer. The shell vials were closed and centrifuged at 1,850 rpm at 25 C for 1 h. After viral adsorption and centrifugation, the urine specimen was removed from each vial, and 2 ml MEM supplemented with 2% FCS was added to each vial. The cultures were incubated at 37 C in a humidified 5% CO 2 atmosphere for 24 h. Cell monolayers were stained by using the monoclonal anti-hcmv immediate-early antigen (Argene, Biosoft, LabConsult SA, Brussels, Belgium) according to the manufacturer s instructions. HCMV-positive cells were counted by visual screening with a fluorescence microscope. Quantitative PCR assay. A quantitative PCR was designed in the major capsid gene region of the HCMV genome to amplify a 340-bp fragment (5). Briefly, a 50- l TaqMan PCR was carried out using 10 l of extracted DNA, 20 l of2 universal master mix containing 6-carboxyl-X-rhodamine as a passive reference (Applied Biosystems), 0.25 M forward primer 5 -CGTAACGTGGACCTGAC GTTT-3, 0.25 M reverse primer 5 -CACGGTCCCGGTTTAGCA-3, and 0.20 M probe 5 -TATCTGCCCGAGGATCGCGGTTACA-3. The probe was labeled at the 5 end with the fluorescent dye 6-carboxyfluorescein as the reporter dye, and the 3 end was labeled with the quencher dye 6-carboxytetramethylrhodamine (Eurogentec, Seraing, Belgium). Amplification and detection were performed using an ABI Prism 7700 sequence detection system (Applied Biosystems) under the following conditions: an initial annealing step for 2 min at 50 C, followed by a PCR activation step at 95 C for 10 min and 45 cycles of amplification (15 s at 95 C and 1 min at 60 C). During amplification, the ABI Prism sequence detector monitored real-time PCR amplification by the quantitative analysis of fluorescence emissions. The reporter dye (6-carboxyfluorescein) signal was measured against the internal reference dye (6-carboxyl-X-rhodamine) signal to normalize for non-pcr-related fluorescence emissions. The threshold cycle was defined as the fractional cycle number at which the reporter fluorescence, generated by the cleavage of the probe, reaches a threshold defined as 10 times the standard deviation of the mean baseline emission between cycles 3 and 15. Statistical analysis. All statistical tests were carried out using SPSS version The significance level was set at P RESULTS Statistical description of data set. Between April 2002 and April 2004, a total of 128,765 babies were born in the Flemish region of Belgium. Of these, 3,497 were born in neonatal intensive care units, and 925 babies died during the first 6 weeks after birth. Due to the network of Child & Family, 92% of the babies born in this period (i.e., 118,438 babies) were screened for possible hearing impairment using the AABR or Algo test in a two-phase screening. Group 1 consists of 58 babies without confirmed hearing impairment who tested positive for both hearing tests or had an inconclusive result. Group 2 comprised 136 babies who had confirmed hearing impairment with an inconclusive result or with positive results on both hearing tests. In total, 332 controls were matched (Fig. 1). Hearing impairment at birth was confirmed by an audiological center in 136 (25.9%) out of the 526 tested babies (all babies in group 2), while 390 (74.1%) tested babies proved to have normal hearing. A urine sample was collected from all babies, and a cell culture assay for the detection of HCMV was carried out on these samples. The average time between the date of the birth of the baby and the sample testing date was 49 days (42 days [range, 10 to 125 days] for controls, 67 days [range, 14 to 266 days] for group 1, and 57 days [range, 13 to 322 days] for group 2). By using the assay, a total of 29 babies (5.5%) tested positive for the presence of HCMV, of which 11 babies belonged to the control group, 4 to group 1, and 14 to group 2. Four hundred ninety-one (93.3%) babies tested negative (317
3 3566 VERBEECK ET AL. J. CLIN. MICROBIOL. TABLE 1. Distribution of the samples in the different groups according to the results of the assay and the quantitative PCR assay Negative quantitative PCR result Positive quantitative PCR result Group negative positive undefined negative positive undefined Control Total Total controls, 54 in group 1, and 120 in group 2). For six children (1.1%), the result of the assay was undefined (four controls and two babies in group 2). Sensitivity of quantitative PCR assay. A quantitative PCR was designed to search for false-negative or false-positive results (5). All samples from patients and controls were analyzed in duplicate, and the same positive control was used for each run. A no-template control (to which H 2 O was added instead of extracted DNA) was used as the negative control. The quantitation standard curve was achieved by using 10-fold serial dilutions of HCMV DNA, corresponding to copy numbers per milliliter of to The slope of the obtained standard curve was 3.36, and the Y intercept (i.e., the theoretical threshold cycle [C T ] value to detect one copy) was With these values, the following formula could be generated for the quantitation of HCMV DNA in the samples: log HCMV copies/milliliter (C T 45.7)/ Viral loads between 1.86 and 7.48 log copies/ml were detected. By using this quantitative PCR, 489 urine samples tested negative for the presence of HCMV, and 37 samples were positive. The samples that were undefined based on the cell culture assay results now could be unambiguously interpreted (Table 1). Urine samples that were found to be positive by our quantitative PCR are defined as true positives. Association between the presence of HCMV and confirmed hearing impairment. A possible association between the presence of HCMV and confirmed hearing impairment for the different groups was examined statistically. Table 2 shows the number of infants in each group according to the presence or absence of HCMV in their urine. Based on the results of both the assay and the quantitative PCR, the number of infants in group 2 that are HCMV positive (10.3% for cell culture assay and 12.5% for quantitative PCR) is three times higher than that of the HCMV-positive samples in the control group (3.3% for assay and 4.5% for quantitative PCR). A Pearson chi-square test indicated that this difference was statistically significant ( ; P 0.002) for the results of the assay. There was no significant difference between the babies of group 1 and those of group 2 ( ; P 0.44) and between the control group and group 1 (Fisher s exact test, P 0.257), although there are approximately two times more HCMV infections in group 1 than in the control group. The same statistical analysis was repeated with the results of the quantitative assay. Again, the Pearson chi-square test indicated that more babies tested positive in group 2 than in the control group ( ; P 0.002). No significant difference could be detected between controls and infants in group 1 (Fisher s exact test, P 0.197) or between infants in group 1 and infants in group 2 ( ; P 0.43). To ensure that this significant result was not an artifact caused by a possible difference in the delay of sample arrival between the controls and group 2, we calculated the average time between the date of birth and the date of sample arrival for both groups (42 days [range, 10 to 125 days] for controls and 57 days [range, 13 to 322 days] for group 2). A nonparametric Mann-Whitney test showed that the average time for group 2 was significantly higher (P ) than that of the control group, indicating that urine samples of infants in the control group were collected and analyzed sooner after birth. This finding also suggests that for babies in group 2, there was a significantly longer perinatal time period in which they could be infected with HCMV. HCMV viral load and confirmed hearing impairment. We also examined a possible relationship between viral load and confirmed hearing impairment. Figure 2 shows the percentage of children with congenital HCMV infection and assigned hearing loss according to the virus quantity in the urine sam- TABLE 2. Number (percentage) of babies in the three different groups according to the presence or absence of HCMV, as defined by the assay and the quantitative PCR Group No. (%) HCMV positive by: Cell culture Quantitative PCR No. (%) HCMV negative by: Cell culture Quantitative PCR 1 4 (6.9) 5 (8.6) 54 (93.1) 53 (91.4) 2 14 (10.3) 17 (12.5) 120 (88.2) 117 (86.1) Control 11 (3.3) 15 (4.5) 317 (95.5) 317 (95.5) FIG. 2. Viral loads (log copies/milliliter of urine) in HCMV-positive urine samples for children with confirmed hearing impairment (white bars) and controls (black bars) as defined by using the quantitative PCR.
4 VOL. 46, 2008 PERINATAL CMV INFECTION AND HEARING IMPAIRMENT 3567 TABLE 3. Number of infants with unilateral and bilateral hearing loss according to the presence of HCMV as determined by the quantitative PCR a HCMV status No. assigned hearing loss at birth ples. Almost 60% of the infants with confirmed hearing loss had viral loads of at least 4.5 log copies/ml, suggesting a positive correlation between viral load and hearing impairment. The odds ratio is (95% confidence interval, to 38.61), and children with a viral load of 4.5 log copies/ml or higher are 1.4 times more likely to have confirmed hearing impairment than children with lower viral loads. Follow-up of babies with confirmed hearing impairment. All infants with confirmed hearing loss soon after birth were invited to participate in a follow-up study to evaluate their hearing abilities after 24 months. After this time, data for 70 infants could be collected. We were most interested in children with unilateral hearing loss who were HCMV positive, because they are at high risk for developing bilateral hearing loss. Table 3 shows the number of infants with unilateral or bilateral hearing loss (determined at birth and after 24 months) according to the presence or absence of HCMV at birth or soon after birth. Of the four children, all four were HCMV positive, with unilateral hearing impairment at birth, and one developed bilateral hearing loss after 24 months. Of the HCMV-positive children with bilateral hearing loss at birth, none showed hearing improvement during the follow-up period. In contrast, three children with bilateral hearing loss at birth who were HCMV negative evolved to a unilateral hearing loss status after 24 months. Nine HCMV-negative children with bilateral hearing loss at birth, and six with unilateral hearing loss, did not show hearing impairment after 24 months. None of the children had developed delayed-onset hearing loss at the end of the study. DISCUSSION No. assigned hearing loss after 24 mo Unilateral Bilateral Unilateral Bilateral None Positive Negative Total a Only data from infants for whom results were available at birth and after a 24-month follow-up were used. Until 1997, the detection of hearing deficits in infants was performed with the Ewing test (a behavioral test) at the age of approximately 9 months. Revalidation procedures for infants with partial or total hearing loss started at the age of 2 years, which is too late for attaining optimal results. Since 1998, hearing screening is performed at the age of 4 to 6 weeks with the AABR, and the integral revalidation of the infants starts at the age of 3 months. The Flanders region in Belgium was the first geographical region where hearing screening was offered to virtually all newborns. The Child & Family public agency succeeds in screening more than 90% of all newborns in Flanders every year, which is a high percentage compared to that of the early hearing detection and intervention programs in America, where 70% of all infants born are screened (31). Moreover, there is almost no loss of the follow-up of referred children with hearing impairment in Belgium. The decision to set up a screening campaign is based on a comparison of the expected benefits and costs of screening and treatment. Moreover, effective and productive screening involves an assessment of the importance of the disease as a public health problem. Neonatal screening for hearing impairment meets all these criteria and therefore is accepted in most countries (4). Most countries choose to perform the neonatal hearing screening before discharge out of the maternity unit. However, different studies have shown that testing soon after birth results in a greater percentage of false-positive results (24, 30), which undermine the credibility of the test and lead to unnecessary pressure for parents and personnel. Also from a therapeutic point of view, there is no reason for testing infants directly after birth, since there are no immediate solutions for hearing improvement and revalidation is offered only from the second or third month after birth. For these reasons, the AABR in Flanders is conducted at the age of 4 to 6 weeks. At this age, the average AABR test time is the shortest, which is another advantage of this policy. Since it is essential to diagnose perinatal HCMV infection with a specific, sensitive, and rapid method, we evaluated a quantitative PCR to detect HCMV in urine samples, and we compared this method to the shell vial assay that is considered the gold standard method for virus isolation from urine. Our results indicate that the quantitative PCR is a sensitive and reliable alternative to the assay. Moreover, results that were uninterpretable with the shell vial assay could be interpreted unambiguously with the quantitative PCR. In our data set, 7% (37 out of 526) of the babies tested positive for the presence of HCMV with the quantitative TaqMan assay, of which 38% (14 out of 37) belonged to group 2. This result indicates that HCMV-infected newborns have a higher risk to develop hearing impairment soon after birth than HCMV-negative babies and that the AABR screening test is a reliable method to identify possible hearing problems in newborns. In total, 12.5% (17/136) of the babies with confirmed hearing impairment were infected with HCMV, and this number equals the numbers found in other studies on HCMV-related sensorineural hearing loss (7, 12, 15, 32). Of the 17 HCMV-positive babies with confirmed hearing impairment, 10 had viral loads above 4.5 log copies/ml urine. This means that babies with a high viral load of at least 4.5 log copies seem to be 1.4 times more likely to have confirmed hearing impairment, although further research with larger datasets is necessary to confirm this finding. Our results indicate that higher viral loads correlate with a higher likelihood of hearing loss. Unfortunately, we did not have additional information for all babies, such as birth weight or other risk factors for HCMV infection, so we could not include these factors in our statistical analysis. Nevertheless, cytomegalovirus viral load determination in the urine of newborns could be an important complement to hearing screening for the early detection of possible hearing loss and, therefore, should be validated as a possible predictive factor for the risk of the development of hearing impairment (14). Since the screening for HCMV was not performed on Guthrie cards or umbilical cord samples but on urine samples that were collected, on average, 49 days after birth, we cannot be sure that the HCMV-positive children were congenitally in-
5 3568 VERBEECK ET AL. J. CLIN. MICROBIOL. fected. The incidence of congenitally acquired HCMV infections is 0.4 to 2.2% (2, 6), and these numbers are lower than the number of HCMV positive children in our data set, which suggests that most infections were acquired perinatally. Sensorineural hearing loss is not always present at birth, and it can begin months or even years after birth (13, 24). Fowler and colleagues showed that the most important decline in hearing occurs during the first year of life (12). For this reason, the intensive follow-up of children at risk for developing hearing impairment is very important. In this study, we evaluated the hearing abilities of 70 children after 24 months and studied the long-term differences between children who were HCMV positive and HCMV negative at birth. The results of our follow-up study suggest that children with HCMV-related hearing impairment experience a continued deterioration of their hearing abilities during childhood, which confirms previous findings (3, 7, 13, 32). Hearing impairment in children who were not infected with HCMV at birth seems to be less profound and has a more temporary nature. These findings could be important in therapeutic interventions, but further research has to be undertaken to study the possible spontaneous amelioration of hearing impairment. Since the early detection of hearing impairment in infants is beneficial for the development of their language skills and for their educational outcome, universal screening for congenital and perinatal HCMV infection could be an important tool to identify children who will profit from intensive audiological follow-up. ACKNOWLEDGMENTS This work was supported by the Flemish Fund for Scientific Research (Fonds voor Wetenschappelijk Onderzoek, FWO), grant G We thank F. Eyskens of the Provinciaal Centrum voor Opsporing van Metabole Aandoeningen, Antwerp, B. Wuyts of the University Hospital, Ghent, and D. Bernard of the Centrum voor Opsporing van Aangeboren Metabole Aandoeningen, Bruges, for their help. We also thank the nurses of Child & Family, Brussels, for collecting the urine samples and our colleagues at the Department of Laboratory Medicine, University Hospital, Leuven, for technical support. REFERENCES 1. Alford, C. A Breast milk transmission of cytomegalovirus (HCMV) infection. Adv. Exp. Med. Biol. 310: Alford, C. A., S. Stagno, R. F. Pass, and W. J. Britt Congenital and perinatal cytomegalovirus infections. Rev. Infect. Dis. 12:S745 S Barbi, M., S. Binda, S. Caroppo, U. Ambrosetti, C. Corbetta, and P. Sergi A wider role for congenital cytomegalovirus infection in sensorineural hearing loss. Pediatr. Infect. Dis. J. 22: Barbi, M., S. Binda, S. Caroppo, and V. Primache Neonatal screening for congenital cytomegalovirus infection and hearing loss. J. Clin. Virol. 35: Beuselinck, K., M. Van Ranst, and J. Van Eldere Automated extraction of viral-pathogen RNA and DNA for high-throughput quantitative real-time PCR. J. Clin. Microbiol. 43: Bradford, R. D., G. Cloud, A. D. Lakeman, S. Boppana, D. W. Kimberlin, R. Jacobs, G. Demmler, P. Sanchez, W. Britt, S. J. Soong, R. J. Whitley, et al Detection of cytomegalovirus (HCMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital HCMV infection involving the central nervous system. J. Infect. Dis. 191: Dahle, A. J., K. B. Fowler, J. D. Wright, S. B. Boppana, W. J. Britt, and R. F. Pass Longitudinal investigations of hearing disorders in children with congenital cytomegalovirus. J. Am. Acad. Audiol. 11: Deben, K., S. Janssens de Varebeke, T. Cox, and P. Van de Heyning Epidemiology of hearing impairment at three Flemish institutes for deaf and speech defective children. Int. J. Pediatr. Otorhinolaryngol. 67: Demmler, G. J Summary of a workshop on surveillance for congenital cytomegalovirus infection. Rev. Infect. Dis. 1113: Desloovere, C., W. Lemmens, L. Feenstra, F. Debruyne, and E. Van Kerschaver Universele gehoorscreening van zuigelingen in Vlaanderen: van droom naar werkelijkheid? Tijdschrift voor Geneeskunde. 56: Dollard, S. D., S. C. Grosse, and D. S. Ross New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev. Med. Virol. 17: Fowler, K. B., A. J. Dahle, S. B. Boppana, and R. F. Pass Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed? J. Pediatr. 135: Fowler, K. B., F. P. McCollister, A. J. Dahle, S. Boppana, W. J. Britt, and R. F. Pass Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J. Pediatr. 130: Grosse, S. D., D. S. Ross, and S. C. Dollard Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment. J. Clin. Virol. 41: Harris, S., K. Ahlfors, S. Ivarsson, B. Lernmark, and L. Svanberg Congenital cytomegalovirus infection and sensorineural hearing loss. Ear Hear. 5: Jacobson, M. A., and J. Mills Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med. 108: Joint Committee on Infant Hearing Year 2000 position statement: principals and guidelines for early hearing detection and intervention programs. Am. J. Audiol. 9: Kenneson, A., and M. J. Cannon Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev. Med. Virol. 17: Kumar, M. L., G. A. Nankervis, I. B. Jacobs, C. B. Ernhart, C. E. Glasson, P. M. McMillan, and E. Gold Congenital and postnatally acquired cytomegalovirus infections: long-term follow-up. J. Pediatr. 104: Medearis, D. N Observations concerning human cytomegalovirus infection and disease. Bull. Johns Hopkins Hosp. 114: Mocarski, E. S., and C. T. Courcelle Cytomegaloviruses and their replication, p In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed., vol. 2. Lippincott Williams & Wilkins, Philadelphia, PA. 22. Nance, W. E., B. G. Lim, and K. M. Dodson Importance of congenital cytomegalovirus infections as a cause for pre-lingual hearing loss. J. Clin. Virol. 35: Pass, R. F Cytomegalovirus, p In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed., vol. 2. Lippincott Williams & Wilkins, Philadelphia, PA. 24. Peckham, C. S., O. Stark, J. A. Dudgeon, J. A. Martin, and G. Hawkins Congenital cytomegalovirus infection: a cause of sensorineural hearing loss. Arch. Dis. Child. 62: Rubin, R. H., N. E. Tolkoff-Rubin, D. Oliver, T. R. Rota, J. Hamilton, R. F. Betts, R. F. Pass, W. Hillis, W. Szmuness, M. L. Farrel, and M. S. Hirsch Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation. Transplantation 40: Sokol, J., and M. Hyde Hearing screening. Pediatr. Rev. 23: Stagno, S., D. W. Reynolds, E. S. Huang, S. D. Thames, R. J. Smith, and C. A. Alford Congenital cytomegalovirus infection. N. Engl. J. Med. 296: Van Kerschaver, E Jaar universele vroegtijdige gehoorscreening in Vlaanderen, organisatie en resultaten. Logopedie 16: Van Kerschaver, E., and L. Stappaerts Universele vroegtijdige gehoorscreening in Vlaanderen met de automatische hersenstam audiometrie. Tijdschrift voor Jeugdgezondheidszorg. 32: Vohr, B. R., K. S. Letourneau, and C. McDermotte Maternal worry about neonatal hearing screening. J. Perinatol. 21: White, K. R The current status of EHDI programs in the United States. Ment. Retard. Dev. Disabil. Res. Rev. 9: Williamson, W. D., G. J. Demmler, A. K. Percy, and F. I. Catlin Progressive hearing loss in infants with asymptomatic congenital cytomegalovirus infection. Pediatrics 90: Winston, D. J., W. G. Ho, and R. E. Champlin Cytomegalovirus infections after bone marrow transplantation. Rev. Infect. Dis. 12:S776 S Yoshinaga-Itano, C., A. L. Sedey, D. K. Coulter, and A. L. Mehl Language of early- and later-identified children with hearing loss. Pediatrics 102:
(AABR) ACCEPTED. Running title: Perinatal CMV infection and hearing impairment. Leuven, Belgium
JCM Accepts, published online ahead of print on 3 September 2008 J. Clin. Microbiol. doi:10.1128/jcm.00757-08 Copyright 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All
More informationCHILDREN WITH CMV: DON T FORGET THE IMPORTANCE OF EARLY INTERVENTION. Paula Pittman, PhD Director, Utah Parent Infant Program for the Deaf
CHILDREN WITH CMV: DON T FORGET THE IMPORTANCE OF EARLY INTERVENTION Paula Pittman, PhD Director, Utah Parent Infant Program for the Deaf STRAW POLL ON CMV 100 people surveyed regarding CMV How many knew
More informationMrs Kate Johnston, Mr Phil Lindsey, Mrs Charlotte Wilson Dr Marieke Emonts, Mrs Ailsa Pickering. Newcastle upon Tyne Hospitals NHS Foundation Trust
'Testing for congenital cytomegalovirus (CMV) in babies identified with permanent childhood hearing impairment (PCHI) through the newborn hearing screening programme (NHSP) Mrs Kate Johnston, Mr Phil Lindsey,
More informationChristine Yoshinaga-Itano, Ph.D. Professor University of Colorado, Boulder Department of Speech, Language & Hearing Sciences Allison Sedey, Ph.D.
Christine Yoshinaga-Itano, Ph.D. Professor University of Colorado, Boulder Department of Speech, Language & Hearing Sciences Allison Sedey, Ph.D. Rosalinda Baca, Ph.D. Molly Dalpes, AuD Kristin Uhler,
More informationEvolution of age at diagnosis of congenital hearing impairment
European Annals of Otorhinolaryngology, Head and Neck diseases (2011) 128, 59 63 ORIGINAL ARTICLE Evolution of age at diagnosis of congenital hearing impairment M. François, C. Hautefort, Y. Nasra, S.
More informationMAJOR ARTICLE. congenital CMV infection; CMV kinetics of clearance; DNAemia at birth; late-onset sequelae.
MAJOR ARTICLE High Cytomegalovirus (CMV) DNAemia Predicts CMV Sequelae in Asymptomatic Congenitally Infected Newborns Born to Women With Primary Infection During Pregnancy Gabriella Forner, 1 Davide Abate,
More informationCLINICAL AUDIT SUMMARY CLINICAL AUDIT SUMMARY. Diagnosis and Recognition of Congenital Cytomegalovirus in Northern Ireland
Regional Virology Issue Date: 08/09/14 Page(s): Page 1 of 6 1.0 Name of audit Diagnosis and Recognition of Congenital Cytomegalovirus in Northern Ireland 2.0 Personnel involved Peter Coyle, Han Lu, Daryl
More informationSUMMARY. Reviews in Medical Virology
Reviews in Medical Virology R E V I E W Rev. Med. Virol. 2007; 17: 355 363. Published online 1 June 2007 in Wiley InterScience (www.interscience.wiley.com).544 New estimates of the prevalence of neurological
More informationabstract ARTICLE BACKGROUND AND OBJECTIVES: Cytomegalovirus (CMV) is the most common congenital infection
Outcomes From a Hearing-Targeted Cytomegalovirus Screening Program Marissa L. Diener, PhD, a Cathleen D. Zick, PhD, a Stephanie Browning McVicar, AuD, CCC-A, b Jill Boettger, MS, CCC-A/SLP, b Albert H.
More informationUntil January 2002, the universal screening programme
78 ORIGINAL ARTICLE Maternal anxiety and satisfaction following infant hearing screening: a comparison of the health visitor distraction test and newborn hearing screening Rachel Crockett, Holly Baker,
More information5. Hospitals will provide the family with a copy of the Michigans Community Program: Information for Parents (MDCH /01). Copies can be ordered,
GUIDELINES FOR HEARING SCREENING A goal of newborn hearing screening is to ensure that all newborns receive a hearing screen before discharge from the hospital or before one month of age. All hospitals
More informationScreening for Congenital CMV Infection
London s Global University Screening for Congenital CMV Infection Venice April 25 2016 Paul D Griffiths MD DSc FRCPath Professor of Virology UCL Institute of Immunity and Transplantation Overview Definition
More informationCongenital Cytomegalovirus (CMV)
August 2011 Congenital Cytomegalovirus (CMV) Revision Dates Case Definition Reporting Requirements Remainder of the Guideline (i.e., Etiology to References sections inclusive) August 2011 August 2011 June
More informationEarly Hearing Detection and Intervention (EHDI): The Role of the Medical Home
Early Hearing Detection and Intervention (EHDI): The Role of the Medical Home A PRESENTATION FROM THE AMERICAN ACADEMY OF PEDIATRICS Hearing Facts Early identification and intervention of a child who is
More informationCongenital CMV infection. Infectious and Tropical Pediatric Division Department of Child Health Medical Faculty, University of Sumatera Utara
Congenital CMV infection Infectious and Tropical Pediatric Division Department of Child Health Medical Faculty, University of Sumatera Utara Congenital CMV infection Approximately 0.15 2% of live births
More informationEffective factors on Auditory Brainstem Response test in Newborns
BIOSCIENCES BIOTECHNOLOGY RESEARCH ASIA, December 2015. Vol. 12(3), 2557-2561 Effective factors on Auditory Brainstem Response test in Newborns Mozafar Sarafraz 1, Maryam Kardooni 1 and Somayeh Araghi
More informationLong-Term Hearing Outcomes of Symptomatic Congenital CMV Infected Children Treated with Valganciclovir
Long-Term Hearing Outcomes of Symptomatic Congenital CMV Infected Children Treated with Valganciclovir Hilary McCrary MD MPH, Xiaoming Sheng PhD, Tom Greene PhD, Albert Park MD University of Utah Disclosures:
More informationCONGENITAL CMV INFECTION
CONGENITAL CMV INFECTION Pablo J. Sánchez, MD 20 th International Symposium on Neonatology.... São Paolo, Brazil 9/10-12/15 HUMAN CYTOMEGALOVIRUS DNA virus; herpesvirus family; 1881 (Ribbert) Infected
More informationaltona RealStar Instructions for Use RealStar CMV PCR Kit /2017 EN DIAGNOSTICS
altona DIAGNOSTICS Instructions for Use RealStar CMV PCR Kit 1.2 08/2017 EN RealStar RealStar CMV PCR Kit 1.2 For research use only! (RUO) 021202 INS-021200-EN-S01 48 08 2017 altona Diagnostics GmbH Mörkenstr.
More informationWomen s Knowledge of Congenital Cytomegalovirus: Baseline Results from the HealthStyles Survey
Women s Knowledge of Congenital Cytomegalovirus: Baseline Results from the HealthStyles Survey Early Hearing Detection and Intervention (EHDI) Centers for Disease Control and Prevention National Center
More informationealth/infectious_diseases/cmv/ Hyde TB et al. (2010) RevMed. Virol.20:
Genetic variability of HCMV strains isolated from Polish pregnant women, their fetuses and newborns W. Wujcicka 1, M. Rycel 1, B. Zawilińska 3, E. Paradowska 4, P. Suski 4, Z. Gaj 1, J. Wilczyński 1,2,
More informationCurr Pediatr Res 2017; 21 (3): ISSN
Curr Pediatr Res 2017; 21 (3): 395-399 ISSN 0971-9032 www.currentpediatrics.com Searching the CMV infection (CMV Ag65 in blood; and CMV-DNA (PCR in perilymphatic fluid) in children with cochlear implant
More informationAUDIOLOGY INFORMATION SERIES ASHA S CONSUMER NEWSLETTER. Hearing Loss and Its Implications for Learning and Communication
AUDIOLOGY INFORMATION SERIES ASHA S CONSUMER NEWSLETTER Vol. 1 No. 2 2000 Hearing Loss and Its Implications for Learning and Communication Hearing Loss and Children: The Facts and Why They Are Important!
More informationJournal of Clinical Virology 40 (2007)
Journal of Clinical Virology 40 (2007) 180 185 Physical and intellectual development in children with asymptomatic congenital cytomegalovirus infection: A longitudinal cohort study in Qinba mountain area,
More informationFaye P. McCollister, EdD University of Alabama, Emeritus National Center for Hearing Assessment and Management
Faye P. McCollister, EdD University of Alabama, Emeritus National Center for Hearing Assessment and Management Karen Fowler, DrPH Department of Pediatrics University of Alabama, Birmingham Studies of etiology
More informationSWISS SOCIETY OF NEONATOLOGY. Symptomatic congenital CMV infection after recurrent maternal infection
SWISS SOCIETY OF NEONATOLOGY Symptomatic congenital CMV infection after recurrent maternal infection May 2017 Mack I, Burckhardt MA, Heininger U, Prüfer F, Wellmann S, Department of Pediatric Infectious
More informationReferral Rates and Costs of Our Modified Two-Step Newborn Hearing Screening Program at a Japanese Perinatal Center
Original Article Elmer Press Referral Rates and Costs of Our Modified Two-Step Newborn Hearing Screening Program at a Japanese Perinatal Center Mieko Sato a, Shunji Suzuki a, b Abstract Background: We
More informationHearing Screening, Diagnostics and Intervention
JCIH Newborn Hearing Screening Guidelines 1-3-6 Model By 1 month Screenhearing Hearing Screening, Diagnostics and Intervention By 3 months: Evaluate hearing and complete diagnosticaudiology and otolaryngology
More informationMaternal oral CMV recurrence following postnatal primary infection in infants
Maternal oral CMV recurrence following postnatal primary infection in infants I. Boucoiran, B. T. Mayer, E. Krantz, S. Boppana, A. Wald, L. Corey, C.Casper, J. T. Schiffer, S. Gantt No conflict of interest
More informationExecutive Summary. JCIH Year 2007 Position Statement: Principles and Guidelines for Early Hearing Detection and Intervention Programs
Executive Summary JCIH Year 2007 : Principles and Guidelines for Early Hearing Detection and Intervention Programs Joint Committee on Infant Hearing Reference this material as: American Speech-Language-Hearing
More informationSaliva Polymerase-Chain-Reaction Assay for Cytomegalovirus Screening in Newborns
T h e n e w e ngl a nd j o u r na l o f m e dic i n e original article Saliva Polymerase-Chain-Reaction Assay for Cytomegalovirus Screening in Newborns Suresh B. Boppana, M.D., Shannon A. Ross, M.D., M.S.P.H.,
More informationCongenital Cytomegalovirus: A Pilot Study
Congenital Cytomegalovirus: A Pilot Study Maggie Dreon Mark Schleiss, Sheila Dollard, Tatiana Lanzieri, Nelmary Hernandez-Alvarado, Carrie Wolf, Kirsten Coverstone, Ruth Lynfield, Mark McCann Special Thanks
More informationEarly Hearing Detection and Intervention
Early Hearing Detection and Intervention ACTION REQUESTED Please co-sponsor and support passage of the Early Hearing Detection and Intervention (EHDI) Act of 2009 (H.R. 1246) that would reauthorize the
More informationCytomegalovirus Seroprevalence among Children 1-5 Years of Age in the United States: The National Health and Nutrition Examination Survey,
CVI Accepts, published online ahead of print on 17 December 2014 Clin. Vaccine Immunol. doi:10.1128/cvi.00697-14 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 2 Cytomegalovirus
More informationHEALTH VISITOR INFORMATION PACK
HEALTH VISITOR INFORMATION PACK NEWBORN HEARING SCREENING WALES Health Visitor Information Pack Contents: 1. Overview - Background Information - The Newborn Hearing Screening Programme for Wales - Methods
More informationCytomegalovirus (CMV) End-Point PCR Kit Product# EP36300
3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: 866-667-4362 (905) 227-8848 Fax: (905) 227-1061 Email: techsupport@norgenbiotek.com Cytomegalovirus (CMV) End-Point PCR Kit Product# EP36300 Product
More informationZika Virus. Robert Wittler, MD
Zika Virus Robert Wittler, MD Disclosure I have no relevant financial relationships with the manufacturers(s) of any commercial products(s) and/or provider of commercial services discussed in this CME
More informationZika Virus. Disclosure. Zika Virus 8/26/2016
Zika Virus Robert Wittler, MD Disclosure I have no relevant financial relationships with the manufacturers(s) of any commercial products(s) and/or provider of commercial services discussed in this CME
More informationExpert opinion on clinical symptoms, management and treatment of infants with congenital cytomegalovirus infection
Expert opinion on clinical symptoms, management and treatment of infants with congenital cytomegalovirus infection J. Gunkel, J. Nijman, M.A. Maciolek-Verboon, T.F.W. Wolfs, L.S. de Vries Financial disclosure
More informationMap of Medicine National Library for Health
Map of Medicine National Library for Health Newborn hearing screening Check eligibility Eligible for screening Not eligible for screening Consider risk factors for hearing loss Provide information and
More informationLong-term Outcomes of Congenital Cytomegalovirus Infection in Sweden and the United Kingdom
MAJOR ARTICLE Long-term Outcomes of Congenital Cytomegalovirus Infection in Sweden and the United Kingdom Claire L. Townsend, 1 Marianne Forsgren, 2 Karin Ahlfors, 3 Sten-Anders Ivarsson, 3 Pat A. Tookey,
More informationCHHA-NL POSITION PAPER. Universal Newborn Hearing Screening Program (UNHSP) in Newfoundland and Labrador
CHHA-NL POSITION PAPER Universal Newborn Hearing Screening Program (UNHSP) in Newfoundland and Labrador Introduction: Approximately 4 in 1,000 Canadian babies are born with some degree of hearing loss
More informationORIGINAL ARTICLE. The Distribution of Risk Factors among High Risk Infants who Failed at Hearing Screening
ORIGINAL ARTICLE The Distribution of Risk Factors among High Risk Infants who Failed at Hearing Screening Figen Baflar, Ayfle Gül Güven Ondokuz May s University Medical Faculty ENT Dept, Audiology Unit.
More informationImpact of the Early Hearing Detection and Intervention Program on the Detection of Hearing Loss at Birth Michigan,
Journal of Educational Audiology 12 (2005) Impact of the Early Hearing Detection and Intervention Program on the Detection of Hearing Loss at Birth Michigan, 1998-2002 Darline K. El Reda, DrPH, MPH, CHES
More informationEarly Hearing Detection & Intervention Programs, Pediatricians, Audiologists & School Nurses use AuDX Screeners
Early Hearing Detection & Intervention Programs, Pediatricians, Audiologists & School Nurses use AuDX Screeners The Portable OAE Hearing Screener of Choice... Ear canal Middle ear Eardrum The AuDX device
More informationJOuRNAL OF CLiNiCAL ViROLOGY 46S (2009) S11 S15
JOURNAL OF CLINICAL VIROLOGY 46S (2009) S11 S15 4 DOCTORS AWARENESS OF CONGENITAL CYTOMEGALOVIRUS AMONG IN THE NETHERLANDS A.M.H. KORVER J.J.C. DE VRIES J.W. DE JONG F.W. DEKKER A.C.T.M. VOSSEN A.M. OUDESLUYS-MURPHY
More informationThe risk factors for conductive and sensorineural
Hearing loss in infants and children may be sensorineural, conductive, or mixed unilateral or bilateral and symmetric or asymmetric. It can also be syndromic (involving other identifiable features) or
More informationaltona RealStar Instructions for Use RealStar CMV PCR Kit /2017 EN DIAGNOSTICS
altona DIAGNOSTICS Instructions for Use RealStar CMV PCR Kit 1.2 08/2017 EN RealStar RealStar CMV PCR Kit 1.2 For use with SmartCycler II (Cepheid) LightCycler 1.2/1.5/2.0 Instruments (Roche) 021212 MAN-021210-EN-S02
More informationPneumocystis Carinii Real Time PCR Kit. For In Vitro Diagnostic Use Only User Manual
Revision No.: ZJ0003 Issue Date: Aug 7 th, 2008 Pneumocystis Carinii Real Time PCR Kit Cat. No.: QD-0082-02 For use with ABI Prism 7000/7300/7500/7900; Smart CyclerII; icycler iq 4/iQ 5; Rotor Gene 2000/3000;
More informationThe Toxoplasma Rubella Cytomegalovirus Herpes (Torch) Infection Risk Factor of Sensorineural Hearing Loss in Children
, 2017, 1(3), 16-21 http://www.hillpublisher.org/journal/ijcemr The Toxoplasma Rubella Cytomegalovirus Herpes (Torch) Infection Risk Factor of Sensorineural Hearing Loss in Children Bambang Udji Djoko
More informationA New Era for the Identification and Treatment of Children with Auditory Disorders
1 A New Era for the Identification and Treatment of Children with Auditory Disorders ROSS J. ROESER AND MARION P. DOWNS Nothing great was ever achieved without enthusiasm. Ralph Waldo Emerson It is a new
More informationThe Role of Cytomegalovirus Evaluation in Pediatric Hearing Loss. Albert Park, MD Dept. Surgery and Pediatrics University of Utah
The Role of Cytomegalovirus Evaluation in Pediatric Hearing Loss Albert Park, MD Dept. Surgery and Pediatrics University of Utah Nondisclosure: Triological Career Development Awardmurine model of CMV induced
More informationPEDIATRIC NEWBORN MEDICINE CLINICAL PRACTICE GUIDELINES. Cytomegalovirus (CMV) Screening Protocol
Clinical Guideline Name Cytomegalovirus (CMV) Screening Protocol Effective Date January 2017 Approved By Department of Pediatric Newborn Medicine Clinical Practice Council_12/8/16_ CWN PPG 12/14/16 BWH
More informationA Diagnostic Paradigm Including Cytomegalovirus Testing for Idiopathic Pediatric Sensorineural Hearing Loss
The Laryngoscope VC 2014 The American Laryngological, Rhinological and Otological Society, Inc. A Diagnostic Paradigm Including Cytomegalovirus Testing for Idiopathic Pediatric Sensorineural Hearing Loss
More informationC M V a n d t h e N e o n a t e D r M e g P r a d o N e o n a t o l o g i s t D i r e c t o r, N I C U, S t F r a n c i s M e d i c a l C e n t e r
C M V a n d t h e N e o n a t e D r M e g P r a d o N e o n a t o l o g i s t D i r e c t o r, N I C U, S t F r a n c i s M e d i c a l C e n t e r C M V S e r o - P r e v a l e n c e ( I g G p o s i t
More informationNewborn hearing screening in Western Australia
Newborn hearing screening in Western Australia Helen D Bailey, Carol Bower, Jay Krishnaswamy and Harvey L Coates ABSTRACT Aim: To report the preliminary findings of a pilot program to screen newborn babies
More informationCMV: perinatal management of infected neonates
CMV: perinatal management of infected neonates ccmv Epidemiology The prevalence of ccmv in developed countries is 04 0 0.4 0.8% In the UK, symptomatic congenital infection was estimated to be 3/1000 in
More informationENLARGEMENT OF THE VEStibular
ORIGINAL ARTICLE Investigation of the Role of Congenital Cytomegalovirus Infection in the Etiology of Enlarged Vestibular Aqueducts Shannon P. Pryor, MD; Gail J. Demmler, MD; Anne C. Madeo, MS; Yandan
More informationEtiology of Severe Sensorineural Hearing Loss in Children: Independent Impact of Congenital Cytomegalovirus Infection and GJB2 Mutations
MAJOR ARTICLE Etiology of Severe Sensorineural Hearing Loss in Children: Independent Impact of Congenital Cytomegalovirus Infection and GJB2 Mutations Hiroshi Ogawa, 1 Tatsuo Suzutani, 2 Yohko Baba, 1,3
More informationTrends in molecular diagnostics
Trends in molecular diagnostics Detection of target genes of interest Quantification Infectious diseases HIV Hepatitis C & B TB / MAC Cytomegalovirus Herpes simplex Varicella zoster CT/GC HPV Profiling
More informationRisk Factors for Late-Onset Hearing Loss in Children
Risk Factors for Late-Onset Hearing Loss in Children Richard Folsom University of Washington Susan Norton Esther Ehrmann Children s Hospital & Regional Medical Center In collaboration with Washington State
More informationCLINICAL MANIFESTATIONS OF HUMAN CYTOMEGALOVIRUS (HCMV)
Open Access Research Journal www.pradec.eu Medical and Health Science Journal, MHSJ ISSN: 1804-1884 (Print) 1805-5014 (Online) Volume 12, 2012, pp.34-39 CLINICAL MANIFESTATIONS OF HUMAN CYTOMEGALOVIRUS
More informationNewborn screening for cytomegalovirus
Newborn screening for cytomegalovirus External review against programme appraisal criteria for the UK National Screening Committee (UK NSC) Version: Final Bazian Ltd. October 2017 This analysis has been
More informationDeaf Children and Young People
Deaf Children and Young People Professor Barry Wright Clinical Lead - National Deaf Children Young People and Family Service, York National Deaf Child and Adolescent Mental Health Service (NDCAMHS) Definitions
More informationQuestions and Answers for Pediatric Healthcare Providers: Infants and Zika Virus Infection
1 of 5 01/02/2016 20:39 Questions and Answers for Pediatric Healthcare Providers: Infants and Zika Virus Infection Summary CDC has developed interim guidelines for healthcare providers in the United States
More informationClinical profile of hearing loss in children with congenital cytomegalovirus (CMV) infection: CMV DNA diagnosis using preserved umbilical cord
Acta Oto-Laryngologica, 2011; 131: 976 982 ORIGINAL ARTICLE Clinical profile of hearing loss in children with congenital cytomegalovirus (CMV) infection: CMV DNA diagnosis using preserved umbilical cord
More informationNeonatal Hearing Screening Program in Wallonia and Brussels
EUSUHM 2017 Mind the gap! Building bridges to better health for all young people Session: Early detection of hearing impairment Neonatal Hearing Screening Program in Wallonia and Brussels Bénédicte VOS
More informationProgress in Standardization of Reporting and Analysis of Data from Early Hearing Detection and Intervention (EHDI) Programs
2016; 1(2): 2-7 Progress in Standardization of Reporting and Analysis of Data from Early Hearing Detection and Intervention (EHDI) Programs Suhana Alam,MPH., 1 Ashley Satterfield, MPH., 2 Craig A. Mason,
More information1. Introduction. Correspondence should be addressed to Richard J. Drew; Received 23 July 2015; Accepted 15 November 2015
Infectious Diseases in Obstetrics and Gynecology Volume 2015, Article ID 218080, 5 pages http://dx.doi.org/10.1155/2015/218080 Research Article Pregnancy Outcomes of Mothers with Detectable CMV-Specific
More informationEfficacy of TEOAEs and BERA as screening tools for deafness in newborn
International Journal of Otorhinolaryngology and Head and Neck Surgery Valse D et al. Int J Otorhinolaryngol Head Neck Surg. 2017 Jul;3(3):491-495 http://www.ijorl.com pissn 2454-5929 eissn 2454-5937 Original
More information1 APRIL 2007 TO 31 MARCH
Public Health Screening Programmes Annual Report 1 APRIL 2007 TO 31 MARCH 2008 Extract: Chapter 7: Universal Newborn Hearing Screening Public Health Screening Unit Version 1.0 Published: 16 December 2008
More informationLeukemia BCR-ABL Fusion Gene Real Time RT-PCR Kit
Revision No.: ZJ0003 Issue Date: Aug 7 th, 2008 Leukemia BCR-ABL Fusion Gene Real Time RT-PCR Kit Cat. No.: TR-0126-02 For use with ABI Prism 7000/7300/7500/7900(96 well); Smart Cycler II; icycler iq 4/iQ
More informationInstructions for Use. RealStar Influenza S&T RT-PCR Kit /2017 EN
Instructions for Use RealStar Influenza S&T RT-PCR Kit 3.0 01/2017 EN RealStar Influenza S&T RT-PCR Kit 3.0 For research use only! (RUO) 163003 INS-163000-EN-S02 96 01 2017 altona Diagnostics GmbH Mörkenstr.
More informationCytomegalovirus Infection in the Fetus and Neonate Elizabeth K. Stehel and Pablo J. Sánchez. DOI: /neo.6-1-e38
Cytomegalovirus Infection in the Fetus and Neonate Elizabeth K. Stehel and Pablo J. Sánchez NeoReviews 2005;6;e38-e45 DOI: 10.1542/neo.6-1-e38 The online version of this article, along with updated information
More informationMINNESOTA EARLY HEARING DETECTION AND INTERVENTION (EHDI) PROGRAM. EHDI Goals, Indicators and Benchmarks
Protecting, maintaining and improving the health of all Minnesotans MINNESOTA EARLY HEARING DETECTION AND INTERVENTION (EHDI) PROGRAM EHDI Goals, Indicators and Benchmarks The measures described in this
More informationProspective Identification of Congenital Cytomegalovirus Infection in Newborns Using Real-Time Polymerase Chain Reaction Assays in Dried Blood Spots
MAJOR ARTICLE Prospective Identification of Congenital Cytomegalovirus Infection in Newborns Using Real-Time Polymerase Chain Reaction Assays in Dried Blood Spots Marianne Leruez-Ville, 1 Christelle Vauloup-Fellous,
More informationInternational Journal of Research and Review E-ISSN: ; P-ISSN:
International Journal of Research and Review www.gkpublication.in E-ISSN: 2349-9788; P-ISSN: 2454-2237 Review Article A Pooled Estimate of the Global Prevalence of Congenital CMV and Clinical Sequelae
More informationHistorical Perspective. JCIH 1973 Position Statement. JCIH Goals. JCIH 1982 Position Statement
Historical Perspective Effects of Policy Changes on Universal Newborn Hearing Screening Follow up Lata A. Krishnan, PhD, CCC A Shannon Van Hyfte, AuD, CCC A Purdue University The Joint Committee on Infant
More informationThe Colorado Newborn Hearing Screening Project, : On the Threshold of Effective Population-Based Universal Newborn Hearing Screening
The Colorado Newborn Hearing Screening Project, 1992 1999: On the Threshold of Effective Population-Based Universal Newborn Hearing Screening Albert L. Mehl, MD*, and Vickie Thomson, MA, CCC-A ABSTRACT.
More informationCMV. Your questions answered. Contact us on us Visit December 2013 Edition
CMV Your questions answered Contact us on 0845 467 9590 Email us info@cmvaction.org.uk Visit www.cmvaction.org.uk December 2013 Edition Your Questions Answered 02 The basics about the virus 04 Transmission
More informationNewborn Screening Free health checks for your baby. Newborn. Hearing Screening. Your Baby s Hearing Screen
Newborn Screening Free health checks for your baby Newborn Hearing Screening Your Baby s Hearing Screen All babies are checked at birth to see that all is well. Some of your baby s health checks are called
More informationCMV DNA Quantification Using an Automated Platform for Nucleic Acid Extraction and Real- time PCR Assay Set-up
JCM Accepts, published online ahead of print on 11 May 2011 J. Clin. Microbiol. doi:10.1128/jcm.00721-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationT he late diagnosis of bilateral congenital hearing impairment
245 ORIGINAL ARTICLE Six year effectiveness of a population based two tier infant hearing screening programme S A Russ, F Rickards, Z Poulakis, M Barker, K Saunders, M Wake... See end of article for authors
More informationHIV-1 Viral Load Real Time (RG)
-1 Viral Load Real Time (RG) Real Time RT-PCR type 1 RNA quantification assay MSP Reg. pending Valdense 3616. 11700. Montevideo. Uruguay. phone (598) 2 336 83 01. Fax (598) 2 336 71 60. Info@atgen.com.uy
More informationInstructions for Use. RealStar Influenza Screen & Type RT-PCR Kit /2017 EN
Instructions for Use RealStar Influenza Screen & Type RT-PCR Kit 4.0 05/2017 EN RealStar Influenza Screen & Type RT-PCR Kit 4.0 For research use only! (RUO) 164003 INS-164000-EN-S01 96 05 2017 altona
More informationEHDI Conference 2009 Addison, TX
Update on the Joint Committee on Infant Hearing Activities EHDI Conference 2009 Addison, TX Judith Widen - University of Kansas Medical Center - Kansas City, KS Judith Harrison, AG Bell Association Washington,
More information3/20/2017. D. Richard Kang, MD, FACS, FAAP Pediatric Otolaryngology Director, ENT Institute Boys Town National Research Hospital
D. Richard Kang, MD, FACS, FAAP Pediatric Otolaryngology Director, ENT Institute Boys Town National Research Hospital Pediatric providers have a reasonable chance to see a child with hearing loss in your
More informationKANSAS GUIDELINES FOR INFANT AUDIOLOGIC ASSESSMENT
KANSAS GUIDELINES FOR INFANT AUDIOLOGIC ASSESSMENT SoundBeginnings Early Hearing Detection and Intervention Program Kansas Department of Health & Environment 1000 SW Jackson Ste. 220 Topeka, Kansas 66612-1274
More informationthe time is now: wisconsin s journey towards improving early intervention services
Marcy Dicker is the director of Outreach for the Wisconsin Educational Services Program for the Deaf and Hard of Hearing. Her background is in providing services to young children, birth to age 3, who
More informationA PROGRAMMATIC ANALYSIS OF A NEWBORN HEARING SCREENING PROGRAM FOR EVALUATION AND IMPROVEMENT
A PROGRAMMATIC ANALYSIS OF A NEWBORN HEARING SCREENING PROGRAM FOR EVALUATION AND IMPROVEMENT by VICKIE RAE THOMSON B.S. University of Northern Colorado, 1977 M.A. University of Northern Colorado, 1979
More informationAUDIOLOGICAL TESTING OF COCHLEAR IMPLANTED CHILDREN IN AN EARLY INTERVENTION PROGRAMME IN SOUTH AFRICA
AUDIOLOGICAL TESTING OF COCHLEAR IMPLANTED CHILDREN IN AN EARLY INTERVENTION PROGRAMME IN SOUTH AFRICA Moodley, S. & Störbeck, C. HI HOPES Early Intervention Programme, University of the Witwatersrand
More informationLaboratory diagnosis of congenital infections
Laboratory diagnosis of congenital infections Laboratory diagnosis of HSV Direct staining Tzanck test Immunostaining HSV isolation Serology PCR Tzanck test Cell scrape from base of the lesion smear on
More informationThe Two I s in EHDI: Intervention and Impact. Teresa H. Caraway, Ph.D., CCC-SLP, LSLS Cert. AVT Hearts for Hearing Oklahoma City, OK
The Two I s in EHDI: Intervention and Impact Teresa H. Caraway, Ph.D., CCC-SLP, LSLS Cert. AVT Hearts for Hearing Oklahoma City, OK Hearing Loss Facts: Brief Overview The most common birth anomaly: 2 to
More informationChildhood Hearing Clinic causes of congenital hearing loss Audit of results of investigations
Childhood Hearing Clinic causes of congenital hearing loss Audit of results of investigations Dr Karen Liddle - 20th May 2017 9th Australasian Newborn Screening Conference Childhood Hearing Clinic Multidisciplinary
More informationSome Permanent Hearing Loss is Missed When Switched Ear Passes are Combined for Determining Screening Results
2017; 2(2): 48-55 Some Permanent is Missed When Switched Ear Passes are Combined for Determining Screening Results Beverly Gail Lim, ARNP, AuD 1 Maria Perez-Abalo, MD, PhD 1 Jillian Gerstenberger, AuD
More informationThe Two I s in EHDI: Intervention and Impact. Teresa H. Caraway, Ph.D., CCC-SLP, LSLS Cert. AVT Hearts for Hearing Oklahoma City, OK
The Two I s in EHDI: Intervention and Impact Teresa H. Caraway, Ph.D., CCC-SLP, LSLS Cert. AVT Hearts for Hearing Oklahoma City, OK As the CEO of EI Services Hearing Loss Facts: Brief Overview The most
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/18641 holds various files of this Leiden University dissertation. Author: Vries, Jutte Jacoba Catharina de Title: Congenital cytomegalovirus infection :
More informationNewborn hearing screening - well baby protocol Paediatrics > Screening > Newborn hearing screening
Map of Medicine National Library for Health Newborn hearing screening well baby protocol Automated oto-acoustic emission (AOAE) screening test Missed or incomplete AOAE screening test AOAE no clear response
More informationSUMMARY. Reviews in Medical Virology. Rev. Med. Virol. (2011) Published online in Wiley Online Library (wileyonlinelibrary.com) DOI: /rmv.
Reviews in Medical Virology R E V I E W Rev. Med. Virol. (2011) Published online in Wiley Online Library (wileyonlinelibrary.com).679 Implementing neonatal screening for congenital cytomegalovirus: addressing
More information